Valo Health
About Valo Health
Valo Health is a biotechnology company that leverages artificial intelligence (AI) and large-scale human-centric data to revolutionize drug discovery and development. The company’s core offering is the Opal Computational Platform™, an integrated system that combines machine learning, cloud computing, tissue biology, and patient data. This platform is designed to accelerate the identification of novel disease targets, engineer new small molecules, predict patient benefit, and optimize clinical trial design and execution.
Valo Health’s approach aims to address the inefficiencies of traditional drug development by creating a closed-loop system that integrates computational and empirical methods. By analyzing vast datasets, including clinical records, genomic information, proteomes, metabolomes, microbiomes, and radiographic images, Valo seeks to uncover causal relationships between genetic markers and diseases. This data-driven strategy is intended to lead to more impactful drug targets and therapeutics, developed faster and with greater precision, ultimately reducing costs, time, and failure rates in bringing life-changing treatments to patients.
The company’s initial therapeutic focus areas include cardiovascular diseases, neurodegeneration, and oncology, as well as metabolic and renal diseases. Valo Health aims to develop its own proprietary drug candidates internally, utilizing its Opal platform as the primary discovery tool, and also engages in strategic partnerships with other pharmaceutical companies.
Focus Areas
Business Intelligence
| Key Investors | Flagship Pioneering, Public Sector Pension Investment Board (PSP Investments), HBM Healthcare Investments, Invus Public Equities, Atinum Investment, Mirae Asset Capital, Koch Disruptive Technologies, Khosla Ventures, NG MGG Strategic, Caz Investments, State of Michigan Retirement Systems, Longevity Vision Fund, Titan Holdings, E Squared Capital Management, Hercules Capital (San Mateo) |
| Partnerships | Novo Nordisk, Charles River Laboratories, The Michael J. Fox Foundation |
| Acquisitions | Numerate (2019), Courier Therapeutics (2021), TARA Biosystems (2022) |
| Technology | Opal Computational Platform, AI-enabled human causal biology, closed-loop chemistry, cloud-native |
What Physicians Need to Know
For physicians, Valo Health's approach means a potential for faster development of more effective and safer drugs, particularly in challenging areas like neurodegeneration, oncology, and cardiometabolic diseases. Their use of extensive human-centric data and AI aims to identify novel drug targets grounded in human evidence, predict patient response, and design more efficient clinical trials. This could lead to therapies that are better tailored to specific patient subtypes and have a higher probability of success in clinical settings, ultimately offering new and improved treatment options.
Valo Health's Opal Computational Platform is designed as an end-to-end workflow. They also engage in strategic partnerships, such as collaborations with Merck KGaA for neurodegenerative disorders and Novo Nordisk for cardiometabolic diseases, and Charles River Laboratories for AI-powered drug discovery (Logicau00ae). Their technology stack includes Cloudflare, Cloudflare DNS, and Microsoft 365, along with various programming languages (Python, R, Java, JavaScript, SQL, TypeScript, Matlab), databases (Cassandra, MySQL, Neo4j, Oracle, Snowflake, SQLite), and frameworks (Docker, Express, Flask, Jupyter, Kubernetes, React, Redux, Scikit, Spring, Terraform, Vue.js, Vuex). They also partner with nference for real-time access to a wide range of data modes, including insights from physicians' notes, medical imaging, and outcomes data.
What the Web Says
Valo Health is a technology company focused on transforming drug discovery and development using AI and human-centric data. They aim to accelerate the creation of life-changing drugs while reducing costs, time, and failure rates. While the company is praised for its innovative technology and mission, employee morale has been impacted by layoffs and restructuring.
Overall: MixedStrengths
- Incredible and disruptive technology for drug discovery and development.
- Great pay and benefits.
- Supportive and inclusive work environment with great colleagues.
- Strong emphasis on work-life balance.
- Offers company equity and performance bonuses.
- Dedicated diversity and inclusion staff and initiatives.
Limitations
- Layoffs and restructuring have diminished employee morale.
- Poor prospects for career advancement; official guidelines not always followed.
- Management issues and lack of accountability in some areas.
- Limited resources and changing priorities can be stressful.
- Job security concerns.
- Some reviews for a product named 'Valo' (not explicitly 'Valo Health') on G2 and Capterra are for different software products (e.g., AI coding assistants, collaboration tools, EHR systems, red light therapy devices), making it difficult to find specific product reviews for Valo Health's drug discovery platform.
Based on reviews from: Indeed.com, BioHackingTested.com, G2.com, Valohealth.com, SimplyHired.com, BuiltIn.com, PitchBook.com, Reddit.com, Capterra.com, PR Newswire, BBB Scam Tracker
Last updated: 2026-08-25
Videos
News, demos, and interviews about Valo Health.
Videos load interactively. If none appear, search YouTube for Valo Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Valo Health.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]